首页 > 最新文献

Central European Journal of Immunology最新文献

英文 中文
Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer. 光动力疗法增强奥沙利铂诱导的大肠癌癌症免疫原性细胞死亡。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 Epub Date: 2023-09-29 DOI: 10.5114/ceji.2023.132053
Xiaobo Wang, Lei Ren, Linhan Ye, Jing Cao

Colorectal cancer is one of the most frequently diagnosed cancers. Immunotherapy has been proven to be a potential treatment option for colorectal cancer. Colorectal cancer maintains immune escape by expressing low immunogenicity and following the tolerogenic cell death pathway. There is also emerging evidence that oxaliplatin and photodynamic therapy (PDT) can promote anti-tumor immunity. However, the effect of PDT combined with oxaliplatin on colorectal cancer remains elusive. Here, we analyzed the viability of HCT116 and DLD-1 cell lines after treatment with the combination of PDT and oxaliplatin. We found that the viability decreased significantly after the combination treatment. Meanwhile, we also detected that sinoporphyrin sodium (DVDMS)-derived PDT could amplify oxaliplatin-induced immunogenic cell death (ICD) in different colorectal cancer cell lines. More importantly, the combination of DVDMS-derived PDT and oxaliplatin presented strong immunogenic potential in immunocompetent BALB/c mice in the vaccination assay. Taken together, our data demonstrated that the combination of DVDMS-derived PDT and oxaliplatin is a potential novel therapy for colorectal cancer.

癌症是最常见的癌症之一。免疫疗法已被证明是结直肠癌癌症的一种潜在治疗选择。结直肠癌癌症通过表达低免疫原性并遵循耐受性细胞死亡途径来维持免疫逃避。也有新的证据表明,奥沙利铂和光动力疗法(PDT)可以促进抗肿瘤免疫。然而,PDT联合奥沙利铂治疗结直肠癌癌症的效果仍然难以捉摸。在这里,我们分析了用PDT和奥沙利铂联合治疗后HCT116和DLD-1细胞系的生存能力。我们发现,在联合治疗后,生存能力显著下降。同时,我们还检测到,血卟啉钠(DVDMS)衍生的PDT可以放大不同结直肠癌癌症细胞系中奥沙利铂诱导的免疫原性细胞死亡(ICD)。更重要的是,在疫苗接种试验中,DVDMS衍生的PDT和奥沙利铂的组合在免疫活性BALB/c小鼠中表现出强大的免疫原性潜力。总之,我们的数据表明,DVDMS-derived PDT和奥沙利铂联合治疗结直肠癌癌症是一种潜在的新疗法。
{"title":"Photodynamic therapy augments oxaliplatin-induced immunogenic cell death in colorectal cancer.","authors":"Xiaobo Wang,&nbsp;Lei Ren,&nbsp;Linhan Ye,&nbsp;Jing Cao","doi":"10.5114/ceji.2023.132053","DOIUrl":"https://doi.org/10.5114/ceji.2023.132053","url":null,"abstract":"<p><p>Colorectal cancer is one of the most frequently diagnosed cancers. Immunotherapy has been proven to be a potential treatment option for colorectal cancer. Colorectal cancer maintains immune escape by expressing low immunogenicity and following the tolerogenic cell death pathway. There is also emerging evidence that oxaliplatin and photodynamic therapy (PDT) can promote anti-tumor immunity. However, the effect of PDT combined with oxaliplatin on colorectal cancer remains elusive. Here, we analyzed the viability of HCT116 and DLD-1 cell lines after treatment with the combination of PDT and oxaliplatin. We found that the viability decreased significantly after the combination treatment. Meanwhile, we also detected that sinoporphyrin sodium (DVDMS)-derived PDT could amplify oxaliplatin-induced immunogenic cell death (ICD) in different colorectal cancer cell lines. More importantly, the combination of DVDMS-derived PDT and oxaliplatin presented strong immunogenic potential in immunocompetent BALB/c mice in the vaccination assay. Taken together, our data demonstrated that the combination of DVDMS-derived PDT and oxaliplatin is a potential novel therapy for colorectal cancer.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 3","pages":"189-202"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual cause of rapidly progressive glomerulonephritis associated with ANCA vasculitis and ovarian malignancy - a relapse 39 years after initial treatment. 与ANCA血管炎和卵巢恶性肿瘤相关的快速进展性肾小球肾炎的不寻常原因-在初始治疗后39年复发。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 DOI: 10.5114/ceji.2023.127744
Nikola Simovic, Petar Djuric, Jelena Stojsic, Nada Dimkovic, Radomir Naumovic

A 69-year-old woman presented with severe anemia, proteinuria, microscopic hematuria and rapidly progressive renal failure. She was admitted to the nephrology department due to severe deterioration of renal function with complaints of malaise, fever, dry cough and occasional epistaxis that appeared 2 months prior to admission. Histopathologic examination of a specimen from kidney biopsy and immunologic findings revealed ANCA positive pauci-immune crescentic glomerulonephritis. The patient had a history of ovarian granulosa cell tumor and lung metastases that were treated surgically with postoperative radiotherapy and chemotherapy. Thoracic computed tomography showed tissue neoplasm in the right lung and ultrasound-guided percutaneous transthoracic biopsy confirmed granulosa cell tumor. That was a relapse, thirty-nine years after initial treatment of malignant disease and twenty-four years after surgical resection of metastases from both lungs. Although the association between malignancy and vasculitis has been well known for decades, this is the first described case of ANCA vasculitis associated with any type of gynecological malignancy and glomerulonephritis.

一名69岁女性,表现为严重贫血、蛋白尿、镜下血尿和快速进行性肾衰竭。患者因肾功能严重恶化,入院前2个月出现不适、发热、干咳、偶有鼻出血等主诉,入住肾脏病科。肾活检标本的组织病理学检查和免疫学结果显示ANCA阳性的包囊免疫新月形肾小球肾炎。患者既往有卵巢颗粒细胞瘤及肺转移病史,手术治疗,术后放化疗。胸部计算机断层扫描显示右肺组织肿瘤,超声引导下经皮经胸活检证实颗粒细胞瘤。这是一次复发,在恶性疾病最初治疗39年后,在手术切除两肺转移瘤24年后。虽然恶性肿瘤和血管炎之间的联系已经众所周知了几十年,但这是第一个被描述的ANCA血管炎与任何类型的妇科恶性肿瘤和肾小球肾炎相关的病例。
{"title":"An unusual cause of rapidly progressive glomerulonephritis associated with ANCA vasculitis and ovarian malignancy - a relapse 39 years after initial treatment.","authors":"Nikola Simovic,&nbsp;Petar Djuric,&nbsp;Jelena Stojsic,&nbsp;Nada Dimkovic,&nbsp;Radomir Naumovic","doi":"10.5114/ceji.2023.127744","DOIUrl":"https://doi.org/10.5114/ceji.2023.127744","url":null,"abstract":"<p><p>A 69-year-old woman presented with severe anemia, proteinuria, microscopic hematuria and rapidly progressive renal failure. She was admitted to the nephrology department due to severe deterioration of renal function with complaints of malaise, fever, dry cough and occasional epistaxis that appeared 2 months prior to admission. Histopathologic examination of a specimen from kidney biopsy and immunologic findings revealed ANCA positive pauci-immune crescentic glomerulonephritis. The patient had a history of ovarian granulosa cell tumor and lung metastases that were treated surgically with postoperative radiotherapy and chemotherapy. Thoracic computed tomography showed tissue neoplasm in the right lung and ultrasound-guided percutaneous transthoracic biopsy confirmed granulosa cell tumor. That was a relapse, thirty-nine years after initial treatment of malignant disease and twenty-four years after surgical resection of metastases from both lungs. Although the association between malignancy and vasculitis has been well known for decades, this is the first described case of ANCA vasculitis associated with any type of gynecological malignancy and glomerulonephritis.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 2","pages":"163-166"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/75/25/CEJI-48-50761.PMC10485690.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10587672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome. 常染色体显性高IgE综合征患者口腔颌面部异常。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 Epub Date: 2023-09-05 DOI: 10.5114/ceji.2023.130874
Ildikó Tar, Márta Szegedi, Ewa Krasuska-Sławińska, Edyta Heropolitańska-Pliszka, Ewa A Bernatowska, Elif Öncü, Sevgi Keles, Sukru N Guner, Ismail Reisli, Nevena Gesheva, Elissaveta Naumova, Lydie Izakovicova-Holla, Jiri Litzman, Igor Savchak, Larysa Kostyuchenko, Melinda Erdõs

Autosomal dominant hyper-IgE syndrome (AD-HIES) is an inborn error of immunity (IEI) caused by a dominant-negative mutation in the signal transducer and activator of transcription 3 (STAT 3). This disease is characterized by chronic eczematoid dermatitis, recurrent staphylococcal skin abscesses, pneumonia, pneumatoceles, and extremely high serum IgE levels. Loss-of-function STAT3 mutations may also result in distinct non-immunologic features such as dental, facial, skeletal, and vascular abnormalities, central nervous system malformations and an increased risk for bone fractures. Prophylactic treatment of Candida infections and prophylactic antimicrobial therapy for staphylococcal skin infections and sinopulmonary infections are essential. An awareness of the oral and maxillofacial features of HIES may facilitate early diagnosis with genetic counselling and may improve future patient care. This study describes oral, dental, and maxillofacial manifestations in 14 patients with genetically defined AD-HIES. We also review the literature and propose recommendations for the complex care of patients with this rare primary immunodeficiency.

常染色体显性高IgE综合征(AD-HIES)是一种先天性免疫错误(IEI),由信号转导子和转录激活子3(STAT 3)的显性负突变引起。这种疾病的特点是慢性湿疹样皮炎、复发性葡萄球菌皮肤脓肿、肺炎、气肿和极高的血清IgE水平。STAT3功能缺失突变也可能导致明显的非免疫特征,如牙齿、面部、骨骼和血管异常、中枢神经系统畸形和骨折风险增加。预防性治疗念珠菌感染和预防性抗菌治疗葡萄球菌皮肤感染和窦性肺部感染是必不可少的。了解HIES的口腔和颌面部特征可能有助于通过基因咨询进行早期诊断,并可能改善未来的患者护理。这项研究描述了14名遗传性AD-HIES患者的口腔、牙齿和颌面部表现。我们还回顾了文献,并提出了对这种罕见的原发性免疫缺陷患者进行复杂护理的建议。
{"title":"Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome.","authors":"Ildikó Tar,&nbsp;Márta Szegedi,&nbsp;Ewa Krasuska-Sławińska,&nbsp;Edyta Heropolitańska-Pliszka,&nbsp;Ewa A Bernatowska,&nbsp;Elif Öncü,&nbsp;Sevgi Keles,&nbsp;Sukru N Guner,&nbsp;Ismail Reisli,&nbsp;Nevena Gesheva,&nbsp;Elissaveta Naumova,&nbsp;Lydie Izakovicova-Holla,&nbsp;Jiri Litzman,&nbsp;Igor Savchak,&nbsp;Larysa Kostyuchenko,&nbsp;Melinda Erdõs","doi":"10.5114/ceji.2023.130874","DOIUrl":"10.5114/ceji.2023.130874","url":null,"abstract":"<p><p>Autosomal dominant hyper-IgE syndrome (AD-HIES) is an inborn error of immunity (IEI) caused by a dominant-negative mutation in the signal transducer and activator of transcription 3 (STAT 3). This disease is characterized by chronic eczematoid dermatitis, recurrent staphylococcal skin abscesses, pneumonia, pneumatoceles, and extremely high serum IgE levels. Loss-of-function STAT3 mutations may also result in distinct non-immunologic features such as dental, facial, skeletal, and vascular abnormalities, central nervous system malformations and an increased risk for bone fractures. Prophylactic treatment of Candida infections and prophylactic antimicrobial therapy for staphylococcal skin infections and sinopulmonary infections are essential. An awareness of the oral and maxillofacial features of HIES may facilitate early diagnosis with genetic counselling and may improve future patient care. This study describes oral, dental, and maxillofacial manifestations in 14 patients with genetically defined AD-HIES. We also review the literature and propose recommendations for the complex care of patients with this rare primary immunodeficiency.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"1 1","pages":"228-236"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71071975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exposure duration of ambient fine particulate matter determines the polarization of macrophages. 环境细颗粒物的暴露时间决定了巨噬细胞的极化。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 Epub Date: 2023-09-19 DOI: 10.5114/ceji.2023.130978
Xiangru Li, Hongyan Cai, Wei Wu, Shaoyan Si, Minli Zhu

Ambient fine particulate matter (FPM) promotes airway inflammation and aggravates respiratory and cardiovascular diseases. Macrophage polarization plays an essential role in FPM-induced inflammation and tissue repair. The balance of pro-inflammatory M1-type and anti-inflammatory M2-type macrophages determines the fate of tissues and is involved in the pathogenesis of various FPM-induced diseases. The mechanism of macrophage polarization induced by FPM is still not fully understood. Here, we explored the effect of ambient FPM exposure duration on the polarization of peritoneal macrophages. Mice were exposed to concentrated ambient FPM for different duration. Markers of M1-type macrophage and M2-type macrophage in peritoneal macrophages were detected. We found that macrophage polarization was affected by FPM both in vitro and in vivo. Acute FPM stimulation in vitro and short-term concentrated ambient FPM exposure in vivo promoted the expression of NLRP3 and NOS2 and inhibited the expression of ARG1 and CD206. With the extension of concentrated ambient FPM exposure time, ARG1 was gradually up-regulated, and NLRP3 was gradually down-regulated. These results indicate that FPM exposure duration interferes with macrophage polarization. This may provide new insight into the treatment of patients exposed to FPM.

环境细颗粒物(FPM)会促进气道炎症,加重呼吸道和心血管疾病。巨噬细胞极化在FPM诱导的炎症和组织修复中起着重要作用。促炎M1型和抗炎M2型巨噬细胞的平衡决定了组织的命运,并参与了各种FPM诱导的疾病的发病机制。FPM诱导巨噬细胞极化的机制尚不完全清楚。在此,我们探讨了环境FPM暴露时间对腹膜巨噬细胞极化的影响。小鼠暴露于浓缩的环境FPM不同的持续时间。检测腹腔巨噬细胞中M1型巨噬细胞和M2型巨噬细胞的标志物。我们发现FPM在体外和体内都会影响巨噬细胞的极化。体外急性FPM刺激和体内短期集中环境FPM暴露促进了NLRP3和NOS2的表达,并抑制了ARG1和CD206的表达。随着浓缩环境FPM暴露时间的延长,ARG1逐渐上调,NLRP3逐渐下调。这些结果表明FPM暴露持续时间干扰巨噬细胞极化。这可能为接触FPM的患者的治疗提供新的见解。
{"title":"Exposure duration of ambient fine particulate matter determines the polarization of macrophages.","authors":"Xiangru Li,&nbsp;Hongyan Cai,&nbsp;Wei Wu,&nbsp;Shaoyan Si,&nbsp;Minli Zhu","doi":"10.5114/ceji.2023.130978","DOIUrl":"https://doi.org/10.5114/ceji.2023.130978","url":null,"abstract":"<p><p>Ambient fine particulate matter (FPM) promotes airway inflammation and aggravates respiratory and cardiovascular diseases. Macrophage polarization plays an essential role in FPM-induced inflammation and tissue repair. The balance of pro-inflammatory M1-type and anti-inflammatory M2-type macrophages determines the fate of tissues and is involved in the pathogenesis of various FPM-induced diseases. The mechanism of macrophage polarization induced by FPM is still not fully understood. Here, we explored the effect of ambient FPM exposure duration on the polarization of peritoneal macrophages. Mice were exposed to concentrated ambient FPM for different duration. Markers of M1-type macrophage and M2-type macrophage in peritoneal macrophages were detected. We found that macrophage polarization was affected by FPM both in vitro and in vivo. Acute FPM stimulation in vitro and short-term concentrated ambient FPM exposure in vivo promoted the expression of NLRP3 and NOS2 and inhibited the expression of ARG1 and CD206. With the extension of concentrated ambient FPM exposure time, ARG1 was gradually up-regulated, and NLRP3 was gradually down-regulated. These results indicate that FPM exposure duration interferes with macrophage polarization. This may provide new insight into the treatment of patients exposed to FPM.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 3","pages":"219-227"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presence of tubuloreticular inclusions in ultrastructural studies of renal biopsies in children with lupus nephropathy - one-center preliminary study. 在儿童狼疮肾病肾活检超微结构研究中存在小管网状包裹体-单中心初步研究。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 DOI: 10.5114/ceji.2023.125237
Tomasz Koszutski, Łukasz Mielańczyk, Grażyna Kucharska, Natalia Matysiak, Agnieszka Wiernik, Grzegorz Kudela, Lidia Hyla-Klekot

Introduction: Juvenile systemic lupus erythematosus (jSLE) is an autoimmune disease that develops as a result of multi-level immune dysregulation, including the interferon pathway. Nephropathy develops at an early stage and eventually affects 90% of patients. A renal biopsy allows one to classify lupus nephritis and determine the proper treatment. Biopsy assessment should be done not only in a light microscope but also in a transmission electron microscope (TEM). Its usage may reveal the presence of intracellular tubuloreticular inclusions (TRIs), considered as a morphological marker of interferon hyperactivity.

Material and methods: Renal biopsies of 10 children with jSLE and nephropathy were analyzed in TEM. The location, structure, and size of TRIs were assessed. Demographic data, nephropathy manifestation, non-renal symptoms, and serological activity of lupus were analyzed.

Results: All the patients were female with an average onset at 12.7 years of age and met SLE criteria. Nephropathy manifested with proteinuria (n = 10) and hematuria (n = 6). Glomerular filtration rate (GFR) was normal in all patients. In three children with early disease onset, it manifested with hematological disorders. TRIs were revealed in 7 biopsies, with the highest expression in the youngest children, with peripheral cytopenia, membranous glomerulonephritis, and lupus nephritis.

Conclusions: Demonstration of TRIs in renal biopsies of children with juvenile systemic lupus may confirm the diagnosis of lupus nephritis and is a sign of involvement of the interferon pathway at the early stage of the disease.

青少年系统性红斑狼疮(jSLE)是一种自身免疫性疾病,是包括干扰素途径在内的多层次免疫失调的结果。肾病在早期发展,最终影响90%的患者。肾活检可以对狼疮性肾炎进行分类并确定适当的治疗方法。活检评估不仅应在光镜下进行,还应在透射电子显微镜(TEM)下进行。它的使用可能揭示细胞内管网状内含物(TRIs)的存在,被认为是干扰素过度活跃的形态学标志。材料与方法:对10例小儿sle合并肾病的肾活检进行TEM分析。评估tri的位置、结构和大小。分析了狼疮患者的人口学资料、肾病表现、非肾脏症状和血清学活动性。结果:所有患者均为女性,平均发病年龄为12.7岁,符合SLE标准。肾病表现为蛋白尿(n = 10)和血尿(n = 6)。所有患者肾小球滤过率(GFR)均正常。3例患儿发病早,表现为血液病。7例活组织检查均发现TRIs,以幼童表达最高,伴外周血细胞减少、膜性肾小球肾炎、狼疮性肾炎。结论:幼年系统性狼疮患儿肾活检显示TRIs可能证实狼疮肾炎的诊断,并且是疾病早期干扰素通路参与的标志。
{"title":"Presence of tubuloreticular inclusions in ultrastructural studies of renal biopsies in children with lupus nephropathy - one-center preliminary study.","authors":"Tomasz Koszutski,&nbsp;Łukasz Mielańczyk,&nbsp;Grażyna Kucharska,&nbsp;Natalia Matysiak,&nbsp;Agnieszka Wiernik,&nbsp;Grzegorz Kudela,&nbsp;Lidia Hyla-Klekot","doi":"10.5114/ceji.2023.125237","DOIUrl":"https://doi.org/10.5114/ceji.2023.125237","url":null,"abstract":"<p><strong>Introduction: </strong>Juvenile systemic lupus erythematosus (jSLE) is an autoimmune disease that develops as a result of multi-level immune dysregulation, including the interferon pathway. Nephropathy develops at an early stage and eventually affects 90% of patients. A renal biopsy allows one to classify lupus nephritis and determine the proper treatment. Biopsy assessment should be done not only in a light microscope but also in a transmission electron microscope (TEM). Its usage may reveal the presence of intracellular tubuloreticular inclusions (TRIs), considered as a morphological marker of interferon hyperactivity.</p><p><strong>Material and methods: </strong>Renal biopsies of 10 children with jSLE and nephropathy were analyzed in TEM. The location, structure, and size of TRIs were assessed. Demographic data, nephropathy manifestation, non-renal symptoms, and serological activity of lupus were analyzed.</p><p><strong>Results: </strong>All the patients were female with an average onset at 12.7 years of age and met SLE criteria. Nephropathy manifested with proteinuria (n = 10) and hematuria (n = 6). Glomerular filtration rate (GFR) was normal in all patients. In three children with early disease onset, it manifested with hematological disorders. TRIs were revealed in 7 biopsies, with the highest expression in the youngest children, with peripheral cytopenia, membranous glomerulonephritis, and lupus nephritis.</p><p><strong>Conclusions: </strong>Demonstration of TRIs in renal biopsies of children with juvenile systemic lupus may confirm the diagnosis of lupus nephritis and is a sign of involvement of the interferon pathway at the early stage of the disease.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 1","pages":"26-34"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/5c/CEJI-48-50170.PMC10189577.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9930542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer. 调节性T细胞(treg)及其相关基因在胃癌中的预后价值
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 DOI: 10.5114/ceji.2023.126773
Liang Zheng, Luping Lin, Jintian Song, Sha Huang, Lizhu Chen, Hui Li, Ning Ma, Qingyue Chen, Yigui Chen

Introduction: This study attempted to investigate the potential of a risk model constructed for regulatory T cells (Tregs) and their related genes in predicting gastric cancer (GC) prognosis.

Material and methods: We used flow cytometry to detect the content of CD4+CD25+ Tregs. After detecting expression of five Treg-related genes by quantitative real-time polymerase chain reaction (qRT-PCR), Pearson analysis was employed to analyze the correlation between Tregs and related gene expression. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), colony formation and transwell assays were used to detect the effects of a disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) on cell functions. A prognostic risk model was built after Cox regression analysis. The Kaplan-Meier method was employed to assess how Tregs, 5-gene risk scores and expression of 5 genes were correlated with the survival time.

Results: A significantly increased content of Tregs was found in GC tissues (p < 0.05). 5 Treg- related genes were significantly up-regulated in GC with a positive correlation with the content of Tregs (p < 0.05). Overexpression of ADAMTS12 significantly enhanced the viability, proliferation, migration and invasion of tumor cells. Kaplan-Meier analysis demonstrated poor overall survival and disease-free survival in the high-risk group. The results of survival analysis of Treg content and related gene expression were consistent with those of Cox analysis.

Conclusions: The risk model constructed based on five Treg-related genes can enable effective prediction in the prognosis of GC patients.

摘要:本研究旨在探讨调节性T细胞(regulatory T cells, Tregs)及其相关基因构建的风险模型在胃癌(gastric cancer, GC)预后预测中的潜力。材料与方法:采用流式细胞术检测CD4+CD25+ Tregs的含量。采用实时荧光定量聚合酶链反应(quantitative real-time polymerase chain reaction, qRT-PCR)检测5个treg相关基因的表达后,采用Pearson分析分析treg与相关基因表达的相关性。采用3-(4,5-二甲基噻唑-2-酰基)-2,5-二苯基溴化四唑(MTT)、集落形成和transwell方法检测具有血小板反应蛋白基序12的崩解素和金属蛋白酶(ADAMTS12)对细胞功能的影响。经Cox回归分析,建立预后风险模型。采用Kaplan-Meier法评估Tregs、5个基因风险评分及5个基因表达与生存时间的相关性。结果:GC组织中Tregs含量显著升高(p < 0.05)。5个Treg相关基因在GC中显著上调,且与Treg含量呈正相关(p < 0.05)。过表达ADAMTS12可显著增强肿瘤细胞的活力、增殖、迁移和侵袭能力。Kaplan-Meier分析显示,高危组的总生存期和无病生存期较差。Treg含量及相关基因表达的生存分析结果与Cox分析结果一致。结论:基于5个treg相关基因构建的风险模型能够有效预测GC患者的预后。
{"title":"Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer.","authors":"Liang Zheng,&nbsp;Luping Lin,&nbsp;Jintian Song,&nbsp;Sha Huang,&nbsp;Lizhu Chen,&nbsp;Hui Li,&nbsp;Ning Ma,&nbsp;Qingyue Chen,&nbsp;Yigui Chen","doi":"10.5114/ceji.2023.126773","DOIUrl":"https://doi.org/10.5114/ceji.2023.126773","url":null,"abstract":"<p><strong>Introduction: </strong>This study attempted to investigate the potential of a risk model constructed for regulatory T cells (Tregs) and their related genes in predicting gastric cancer (GC) prognosis.</p><p><strong>Material and methods: </strong>We used flow cytometry to detect the content of CD4<sup>+</sup>CD25<sup>+</sup> Tregs. After detecting expression of five Treg-related genes by quantitative real-time polymerase chain reaction (qRT-PCR), Pearson analysis was employed to analyze the correlation between Tregs and related gene expression. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), colony formation and transwell assays were used to detect the effects of a disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) on cell functions. A prognostic risk model was built after Cox regression analysis. The Kaplan-Meier method was employed to assess how Tregs, 5-gene risk scores and expression of 5 genes were correlated with the survival time.</p><p><strong>Results: </strong>A significantly increased content of Tregs was found in GC tissues (p < 0.05). 5 Treg- related genes were significantly up-regulated in GC with a positive correlation with the content of Tregs (p < 0.05). Overexpression of ADAMTS12 significantly enhanced the viability, proliferation, migration and invasion of tumor cells. Kaplan-Meier analysis demonstrated poor overall survival and disease-free survival in the high-risk group. The results of survival analysis of Treg content and related gene expression were consistent with those of Cox analysis.</p><p><strong>Conclusions: </strong>The risk model constructed based on five Treg-related genes can enable effective prediction in the prognosis of GC patients.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 1","pages":"14-25"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/9a/CEJI-48-50567.PMC10189578.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9930539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection. 不同类型疫苗诱导医务人员SARS-CoV-2抗体水平与自然感染的比较
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 DOI: 10.5114/ceji.2023.125239
Ljiljana Božić, Darija Knežević, Maja Travar, Nataša Miljuš, Miroslav Petković, Jela Aćimović, Jelena Djaković Dević, Miloš P Stojiljković, Dejan Bokonjić, Ranko Škrbić

Introduction: During the last two and a half years, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread around the world. Most of the SARS-CoV-2 vaccines are designed to produce anti-SARS-CoV-2 immunoglobulin G (IgG) against the viral S-glycoprotein. The aim of this study was to measure the anti-S antibody titres among the medical personnel who had been fully vaccinated with different types of vaccines, and to compare them with those who were COVID-19 convalescents.

Material and methods: In this study serum was collected from 261 healthcare workers, of whom 227 were vaccinated, while 34 were recovered participants who were not immunised. Serum samples were collected 21 days after the first dose and 60 and 180 days after the second dose of the vaccines and tested with a commercial ELISA kit.

Results: The highest antibody level (12 AU/ml) was measured in the Pfizer-BioNTech group, followed by Sinopharm (9.3 AU/ml), Sputnik V (5.9 AU/ml), Sinovac (4.6 AU/ml) and Oxford/Astra- Zeneca vaccine (2.5 AU/ml) 60 days after the second dose of the vaccines (90 days after the first dose). The seropositivity rate for mRNA vaccine was 88.5%, for vector vaccines 86.2% and for inactivated vaccines 71.4%. When comparing these antibody levels with COVID-19 convalescents, higher antibody titres were found in vaccinated participants (5.76 AU/ml vs 7.06 AU/ml), but the difference was not significant (p = 0.08).

Conclusions: Individuals vaccinated with mRNA and vector vaccines had a higher seroconversion rate compared to the group vaccinated with inactivated vaccines, or convalescents.

在过去两年半的时间里,严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染在世界各地蔓延。大多数SARS-CoV-2疫苗被设计为产生抗SARS-CoV-2免疫球蛋白G (IgG)来对抗病毒s -糖蛋白。本研究的目的是测量接种了不同类型疫苗的医务人员的抗s抗体滴度,并与COVID-19恢复期的医务人员进行比较。材料和方法:本研究收集了261名卫生保健工作者的血清,其中227人接种了疫苗,34人是未接种疫苗的康复参与者。在第一剂疫苗接种后21天和第二剂疫苗接种后60天和180天采集血清样本,并用商用酶联免疫吸附试验试剂盒进行检测。结果:辉瑞- biontech组抗体水平最高(12 AU/ml),其次是国药(9.3 AU/ml)、Sputnik V (5.9 AU/ml)、科华(4.6 AU/ml)和牛津/阿斯特拉-利康疫苗(2.5 AU/ml),第二次接种后60天(第一次接种后90天)。mRNA疫苗血清阳性率为88.5%,载体疫苗阳性率为86.2%,灭活疫苗阳性率为71.4%。当将这些抗体水平与COVID-19恢复期患者进行比较时,接种疫苗的参与者的抗体滴度更高(5.76 AU/ml vs 7.06 AU/ml),但差异不显著(p = 0.08)。结论:接种mRNA和载体疫苗的个体比接种灭活疫苗或恢复期的个体血清转换率更高。
{"title":"The comparison of SARS-CoV-2 antibody levels in medical personnel induced by different types of vaccines compared to the natural infection.","authors":"Ljiljana Božić,&nbsp;Darija Knežević,&nbsp;Maja Travar,&nbsp;Nataša Miljuš,&nbsp;Miroslav Petković,&nbsp;Jela Aćimović,&nbsp;Jelena Djaković Dević,&nbsp;Miloš P Stojiljković,&nbsp;Dejan Bokonjić,&nbsp;Ranko Škrbić","doi":"10.5114/ceji.2023.125239","DOIUrl":"https://doi.org/10.5114/ceji.2023.125239","url":null,"abstract":"<p><strong>Introduction: </strong>During the last two and a half years, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread around the world. Most of the SARS-CoV-2 vaccines are designed to produce anti-SARS-CoV-2 immunoglobulin G (IgG) against the viral S-glycoprotein. The aim of this study was to measure the anti-S antibody titres among the medical personnel who had been fully vaccinated with different types of vaccines, and to compare them with those who were COVID-19 convalescents.</p><p><strong>Material and methods: </strong>In this study serum was collected from 261 healthcare workers, of whom 227 were vaccinated, while 34 were recovered participants who were not immunised. Serum samples were collected 21 days after the first dose and 60 and 180 days after the second dose of the vaccines and tested with a commercial ELISA kit.</p><p><strong>Results: </strong>The highest antibody level (12 AU/ml) was measured in the Pfizer-BioNTech group, followed by Sinopharm (9.3 AU/ml), Sputnik V (5.9 AU/ml), Sinovac (4.6 AU/ml) and Oxford/Astra- Zeneca vaccine (2.5 AU/ml) 60 days after the second dose of the vaccines (90 days after the first dose). The seropositivity rate for mRNA vaccine was 88.5%, for vector vaccines 86.2% and for inactivated vaccines 71.4%. When comparing these antibody levels with COVID-19 convalescents, higher antibody titres were found in vaccinated participants (5.76 AU/ml vs 7.06 AU/ml), but the difference was not significant (p = 0.08).</p><p><strong>Conclusions: </strong>Individuals vaccinated with mRNA and vector vaccines had a higher seroconversion rate compared to the group vaccinated with inactivated vaccines, or convalescents.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 1","pages":"35-42"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/12/CEJI-48-50172.PMC10189579.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9930545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy evaluation of direct antiviral drugs against hepatitis B virus in improving the degree of liver fibrosis. 乙型肝炎病毒直接抗病毒药物在改善肝纤维化程度方面的疗效评估。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 Epub Date: 2023-06-01 DOI: 10.5114/ceji.2023.127621
Liang Miao, Lihua Cao, Guiqiang Wang

Introduction: The aim of the study was to find an ideal index reflecting inflammation and fibrosis for patients after antiviral treatment, and compare it with imaging examination (liver stiffness measurement - LSM) and traditional liver fibrosis models (APRI and FIB-4).

Material and methods: A total of 77 chronic hepatitis B (CHB) patients who achieved a sustained virological response (SVR) after entecavir (ETV) treatment were included, and the changes of various clinical indicators before and after treatment were compared.

Results: After 78 weeks of ETV treatment, WBC and PLT of 77 patients were significantly increased, while ALT, AST and total bilirubin were significantly decreased (p < 0.05). There was no significant difference in serum creatinine (Cr) or blood urea nitrogen (BUN) compared to the values before treatment (p > 0.05). The three non-invasive liver fibrosis indexes, namely, LSM, APRI and FIB-4, were significantly decreased in 77 patients compared to the values before treatment (p < 0.001).

Conclusions: Acoustic radiation force impulse (ARFI), fibrosis-4 (FIB-4), aspartate aminotransferase-to-platelet ratio index (APRI) have a high consistency with the grading of liver fibrosis, and can be used to evaluate the severity of liver fibrosis. Among them, ARFI has good diagnostic value for the classification of different degrees of liver fibrosis and the best diagnostic accuracy.

简介该研究旨在为抗病毒治疗后的患者寻找一种反映炎症和肝纤维化的理想指标,并将其与影像学检查(肝硬度测量-LSM)和传统肝纤维化模型(APRI和FIB-4)进行比较:共纳入77例经恩替卡韦(ETV)治疗后获得持续病毒学应答(SVR)的慢性乙型肝炎(CHB)患者,比较治疗前后各项临床指标的变化:ETV治疗78周后,77例患者的白细胞和凝乳酶原(PLT)显著升高,而谷丙转氨酶(ALT)、谷草转氨酶(AST)和总胆红素显著降低(P<0.05)。血清肌酐(Cr)和血尿素氮(BUN)与治疗前相比无明显差异(P > 0.05)。77例患者的三个非侵入性肝纤维化指数,即LSM、APRI和FIB-4,与治疗前的数值相比明显下降(P < 0.001):结论:声辐射力脉冲(ARFI)、纤维化-4(FIB-4)、天冬氨酸氨基转移酶与血小板比值指数(APRI)与肝纤维化分级具有较高的一致性,可用于评价肝纤维化的严重程度。其中,ARFI 对不同程度的肝纤维化分级具有较好的诊断价值,诊断准确性最好。
{"title":"Efficacy evaluation of direct antiviral drugs against hepatitis B virus in improving the degree of liver fibrosis.","authors":"Liang Miao, Lihua Cao, Guiqiang Wang","doi":"10.5114/ceji.2023.127621","DOIUrl":"10.5114/ceji.2023.127621","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of the study was to find an ideal index reflecting inflammation and fibrosis for patients after antiviral treatment, and compare it with imaging examination (liver stiffness measurement - LSM) and traditional liver fibrosis models (APRI and FIB-4).</p><p><strong>Material and methods: </strong>A total of 77 chronic hepatitis B (CHB) patients who achieved a sustained virological response (SVR) after entecavir (ETV) treatment were included, and the changes of various clinical indicators before and after treatment were compared.</p><p><strong>Results: </strong>After 78 weeks of ETV treatment, WBC and PLT of 77 patients were significantly increased, while ALT, AST and total bilirubin were significantly decreased (p < 0.05). There was no significant difference in serum creatinine (Cr) or blood urea nitrogen (BUN) compared to the values before treatment (p > 0.05). The three non-invasive liver fibrosis indexes, namely, LSM, APRI and FIB-4, were significantly decreased in 77 patients compared to the values before treatment (p < 0.001).</p><p><strong>Conclusions: </strong>Acoustic radiation force impulse (ARFI), fibrosis-4 (FIB-4), aspartate aminotransferase-to-platelet ratio index (APRI) have a high consistency with the grading of liver fibrosis, and can be used to evaluate the severity of liver fibrosis. Among them, ARFI has good diagnostic value for the classification of different degrees of liver fibrosis and the best diagnostic accuracy.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 2","pages":"126-134"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/27/CEJI-48-50708.PMC10485686.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10569889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma. nivolumab单药治疗青少年恶性黑色素瘤的严重并发症。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 Epub Date: 2023-08-30 DOI: 10.5114/ceji.2023.130864
Aleksandra Grzegorczyk, Zuzanna Marczyńska, Rafał Matkowski, Marcin Ziętek, Wojciech Pietras, Elżbieta Latos-Grażyńska, Krzysztof Kałwak, Iwona Dachowska-Kałwak

This study presents a case of a 17-year-old female patient who had previously undergone surgical resection of melanoma in the right periscapular area. She was administered adjuvant treatment with the PD-1 inhibitor nivolumab as monotherapy. The mechanism of action of this drug is based on increased stimulation of the immune system. The patient developed a series of complications including capillary leak syndrome and hypothyroidism after the fifth cycle of therapy, as a result of dysregulation of immunity. Nivolumab treatment had to be discontinued and glucocorticosteroids were administered as a salvage therapy. After several months, two relapses developed in the subcutaneous tissue - first in the left and then in the right iliac region, confirmed as distant metastases of malignant melanoma, treated with resections of the lesions and intensity-modulated radiation therapy. Follow-up imaging studies and clinical examinations showed no metastases or pathologically enlarged lymph nodes.

本研究报告了一例17岁的女性患者,她之前曾接受过右肩胛骨周围黑色素瘤的手术切除。她接受了PD-1抑制剂nivolumab作为单一疗法的辅助治疗。这种药物的作用机制是基于增加对免疫系统的刺激。由于免疫调节失调,患者在第五个周期的治疗后出现了一系列并发症,包括毛细血管渗漏综合征和甲状腺功能减退。尼沃单抗治疗不得不停止,并给予糖皮质激素作为挽救性治疗。几个月后,皮下组织出现了两次复发——首先是在左侧,然后是在右侧髂区,被确认为恶性黑色素瘤的远处转移,通过切除病变和强度调节放射治疗进行治疗。随访的影像学研究和临床检查显示没有转移或病理性淋巴结肿大。
{"title":"Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma.","authors":"Aleksandra Grzegorczyk,&nbsp;Zuzanna Marczyńska,&nbsp;Rafał Matkowski,&nbsp;Marcin Ziętek,&nbsp;Wojciech Pietras,&nbsp;Elżbieta Latos-Grażyńska,&nbsp;Krzysztof Kałwak,&nbsp;Iwona Dachowska-Kałwak","doi":"10.5114/ceji.2023.130864","DOIUrl":"10.5114/ceji.2023.130864","url":null,"abstract":"<p><p>This study presents a case of a 17-year-old female patient who had previously undergone surgical resection of melanoma in the right periscapular area. She was administered adjuvant treatment with the PD-1 inhibitor nivolumab as monotherapy. The mechanism of action of this drug is based on increased stimulation of the immune system. The patient developed a series of complications including capillary leak syndrome and hypothyroidism after the fifth cycle of therapy, as a result of dysregulation of immunity. Nivolumab treatment had to be discontinued and glucocorticosteroids were administered as a salvage therapy. After several months, two relapses developed in the subcutaneous tissue - first in the left and then in the right iliac region, confirmed as distant metastases of malignant melanoma, treated with resections of the lesions and intensity-modulated radiation therapy. Follow-up imaging studies and clinical examinations showed no metastases or pathologically enlarged lymph nodes.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"1 1","pages":"251-256"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71071960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic active Epstein-Barr virus infection as the basis of neoplasm development. Transformation of chronic lymphocytic leukaemia to NK-cell lymphoma/leukaemia was observed by flow cytometry - a diagnostic report. 慢性活动性EB病毒感染是肿瘤发展的基础。流式细胞术(一份诊断报告)观察了慢性淋巴细胞白血病向NK细胞淋巴瘤/白血病的转化。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-01-01 Epub Date: 2023-09-04 DOI: 10.5114/ceji.2023.130865
Katarzyna Karwicka, Olga Jankowska-Łęcka, Marek Hus

The case report presents a patient with chronic lymphocytic leukaemia that was diagnosed in 2006 in Rotterdam, the Netherlands. In September 2010, the patient was admitted to the Department of Haematology in Poland due to progression of the underlying disease. The clinical problem during treatment was the suspicion of Richter's transformation into another, more aggressive non-Hodgkin lymphoma. The diagnosis was based on the peripheral blood immunophenotype. The patient was diagnosed with an immunoglobulin deficiency. Unfortunately, repeated examinations did not confirm the transformation hypothesis, despite the increasing symptoms. The patient was treated with various therapeutic regimens until May 2021, when an increased number of NK cells was diagnosed in the peripheral blood. NK-cell lymphoproliferative disease was finally diagnosed de novo. Nevertheless, it was found that the patient had active Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) infection. The suspected NK-cell lymphoma/leukaemia was most likely a complication of the active EBV infection and severe immunodeficiency state.

该病例报告介绍了一名2006年在荷兰鹿特丹被诊断为慢性淋巴细胞白血病的患者。2010年9月,由于潜在疾病的进展,患者住进了波兰血液科。治疗期间的临床问题是怀疑里希特转化为另一种更具侵袭性的非霍奇金淋巴瘤。诊断是基于外周血免疫表型。该患者被诊断为免疫球蛋白缺乏症。不幸的是,尽管症状越来越多,但反复检查并没有证实转化假说。该患者接受了各种治疗方案,直到2021年5月,外周血中NK细胞数量增加。NK细胞淋巴增生性疾病最终被重新诊断。然而,发现患者有活动性EB病毒(EBV)和巨细胞病毒(CMV)感染。疑似NK细胞淋巴瘤/白血病很可能是活动性EB病毒感染和严重免疫缺陷状态的并发症。
{"title":"Chronic active Epstein-Barr virus infection as the basis of neoplasm development. Transformation of chronic lymphocytic leukaemia to NK-cell lymphoma/leukaemia was observed by flow cytometry - a diagnostic report.","authors":"Katarzyna Karwicka,&nbsp;Olga Jankowska-Łęcka,&nbsp;Marek Hus","doi":"10.5114/ceji.2023.130865","DOIUrl":"https://doi.org/10.5114/ceji.2023.130865","url":null,"abstract":"<p><p>The case report presents a patient with chronic lymphocytic leukaemia that was diagnosed in 2006 in Rotterdam, the Netherlands. In September 2010, the patient was admitted to the Department of Haematology in Poland due to progression of the underlying disease. The clinical problem during treatment was the suspicion of Richter's transformation into another, more aggressive non-Hodgkin lymphoma. The diagnosis was based on the peripheral blood immunophenotype. The patient was diagnosed with an immunoglobulin deficiency. Unfortunately, repeated examinations did not confirm the transformation hypothesis, despite the increasing symptoms. The patient was treated with various therapeutic regimens until May 2021, when an increased number of NK cells was diagnosed in the peripheral blood. NK-cell lymphoproliferative disease was finally diagnosed de novo. Nevertheless, it was found that the patient had active Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) infection. The suspected NK-cell lymphoma/leukaemia was most likely a complication of the active EBV infection and severe immunodeficiency state.</p>","PeriodicalId":9694,"journal":{"name":"Central European Journal of Immunology","volume":"48 3","pages":"257-266"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Central European Journal of Immunology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1